杜秀兰,张宏,傅新利,张之澧,张梅涧,马永祯.雷络酯片治疗类风湿性关节炎的临床研究[J].,1998,(2):88-91 |
雷络酯片治疗类风湿性关节炎的临床研究 |
Clinical Study on Tripterygium Wilfordii Complex Ester Tablet in Treating Rheumatoid Arthritis |
|
DOI: |
中文关键词: 雷络酯片 雷公藤多甙片 类风湿关节炎 |
英文关键词:Tripterygium Wilfordii Complex Ester Tablet Tripterygium Wilfordii Polycoside Tablet rheumatoid arthritis |
基金项目: |
Author Name | Affiliation | 杜秀兰 | Du Xiulan, Zhang Hong, Fu Xinli, et al (Affiliated Hospital of Shandong Traditional Chinese Medical University, Jinan (250011 | 张宏 | Du Xiulan, Zhang Hong, Fu Xinli, et al (Affiliated Hospital of Shandong Traditional Chinese Medical University, Jinan (250011 | 傅新利 | Du Xiulan, Zhang Hong, Fu Xinli, et al (Affiliated Hospital of Shandong Traditional Chinese Medical University, Jinan (250011 | 张之澧 | Du Xiulan, Zhang Hong, Fu Xinli, et al (Affiliated Hospital of Shandong Traditional Chinese Medical University, Jinan (250011 | 张梅涧 | Du Xiulan, Zhang Hong, Fu Xinli, et al (Affiliated Hospital of Shandong Traditional Chinese Medical University, Jinan (250011 | 马永祯 | Du Xiulan, Zhang Hong, Fu Xinli, et al (Affiliated Hospital of Shandong Traditional Chinese Medical University, Jinan (250011 |
|
Hits: 1339 |
Download times: 937 |
中文摘要: |
观察雷公藤叶制剂──雷络酯片治疗类风湿性关节炎的疗效和毒副作用。方法:采用前瞻性、多中心、随机双盲对照的方法,共观察类风湿性关节炎277例,治疗组140,口服雷络酯片,每次2片,每天3次;对照组137例,口服雷公藤根制剂──雷公藤多甙片,每次 2片,每天 3次,均 6周为 1个疗程。结果:治疗组愈显率 25. 71%,总有效率为86. 43%;对照组愈显率 26. 28%,总有效率为 83. 94%,两组比较无显著性差异(P>0. 05)。不良反应的发生率治疗组为 20. 00%,对照组为 23. 35%,两组比较无显著性差异(P>0. 05)。结论:雷公藤叶制剂的有效性及安生性均同于根制剂。 |
英文摘要: |
To observe the curative effect, toxic and side effect of Tripterygium Wilfordii Complex Ester Tablet (TWT, a preparation of Folium Tripterygium wilfordii) in treating rheumatoid arthritis. Methods: Two hundred and seventy seven patients were observed with prospective, multicentric and random double-blind control method. One hundred and forty cases of TWT group were treated with TWT 2 tablets each time, 3 times a day orally, and the other 137 cases treated with Tripterygium Wilfordii Polycoside Tablet (TPT, a preparation of Radix Tripterygium Wilfordii) 2 tablets each time were taken as control, 3 times a day orally. The therapeutic course for both groups was 6 weeks. Results: The markedly controlled rate of the TWT group was 26. 71% and the total effective rate was 86.43%, while those in the control group were 26. 28% and 83. 94% respectively, the difference between the two groups was insignificant (P>0.05). The occurrence of side-effect in the two groups was 20.00% and 23.35% respectively, also showed no significant difference (P>0.05). Conclusion: The Folium Tripterygium Wilfordii preparation is similar in efficacy and security to the Radix Tripterygium Wilfordii preparation. |
View Full Text View/Add Comment Download reader |
|
|
|